Your browser doesn't support javascript.
loading
The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease.
Wang, Lijian; Trebicka, Estela; Fu, Ying; Ellenbogen, Shiri; Hong, Charles C; Babitt, Jodie L; Lin, Herbert Y; Cherayil, Bobby J.
Affiliation
  • Wang L; Mucosal Immunology Laboratory, Massachusetts General Hospital, Charlestown, USA.
Inflamm Bowel Dis ; 18(1): 112-9, 2012 Jan.
Article in En | MEDLINE | ID: mdl-21351217

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis / Antimicrobial Cationic Peptides / Bone Morphogenetic Protein 6 / Anti-Bacterial Agents Type of study: Etiology_studies Limits: Animals Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis / Antimicrobial Cationic Peptides / Bone Morphogenetic Protein 6 / Anti-Bacterial Agents Type of study: Etiology_studies Limits: Animals Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom